These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 722915)

  • 1. [Buerger's disease, aortitis syndrome and HL-A].
    Yasuda K; Yokota A; Tanabe T
    Nihon Rinsho; 1978 Sep; 36(9):3171-5. PubMed ID: 722915
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of HLA-A9 and HLA-B5 with Buerger's disease.
    McLoughlin GA; Helsby CR; Evans CC; Chapman DM
    Br Med J; 1976 Nov; 2(6045):1165-6. PubMed ID: 990826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA in Buerger's disease.
    Numano F; Sasazuki T; Koyama T; Shimokado K; Takeda Y; Nishimura Y; Mutoh M
    Exp Clin Immunogenet; 1986; 3(4):195-200. PubMed ID: 3274054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Symposium on major histocompatibility antigens (HLA) and diseases. (4) HLA and disease-heart valular disease and aortitis syndrome (author's transl)].
    Naito S
    Nihon Naika Gakkai Zasshi; 1979 Nov; 68(11):1395-9. PubMed ID: 42662
    [No Abstract]   [Full Text] [Related]  

  • 5. Buerger's disease and anticardiolipin antibodies.
    Pereira de Godoy JM; Braile DM
    J Cardiovasc Med (Hagerstown); 2009 Oct; 10(10):792-4. PubMed ID: 19455050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune mechanisms in thromboangiitis obliterans (Buerger's disease): the role of tobacco antigen and the major histocompatibility complex.
    Papa M; Bass A; Adar R; Halperin Z; Schneiderman J; Becker CG; Brautbar H; Mozes E
    Surgery; 1992 May; 111(5):527-31. PubMed ID: 1598672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thromboangiitis obliterans (Buerger's disease). Study of 41 cases].
    Fernández-Miranda C; Rubio R; Vicario JL; Arnaiz A; Fernández Sáez R; Mollejo M; Pulido F; del Palacio A; Lázaro T
    Med Clin (Barc); 1993 Sep; 101(9):321-6. PubMed ID: 8412397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA A and B antigens in Takayasu's arteritis.
    Castro G; Chávez-Peón C; Sánchez-Torres G; Reyes PA
    Rev Invest Clin; 1982; 34(1):15-7. PubMed ID: 6124030
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence for an HLA-linked resistance gene in Buerger's disease.
    de Moerloose P; Jeannet M; Mirimanoff P; Bouvier CA
    Tissue Antigens; 1979 Aug; 14(2):169-73. PubMed ID: 91227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmunological aspects of thromboangiitis obliterans (Buerger's disease).
    Smolen JS; Youngchaiyud U; Weidinger P; Kojer M; Endler AT; Mayr WR; Menzel EJ
    Clin Immunol Immunopathol; 1978 Oct; 11(2):168-77. PubMed ID: 367656
    [No Abstract]   [Full Text] [Related]  

  • 11. Thromboangiitis obliterans (Buerger's disease).
    Mishima Y
    Int J Cardiol; 1996 Aug; 54 Suppl():S185-7. PubMed ID: 9119522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intractable vasculitis syndromes--incidence and epidemiology].
    Tanabe T
    Nihon Rinsho; 1994 Aug; 52(8):1987-91. PubMed ID: 7933574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenetics of peripheral arteriopathies.
    Mehra NK; Jaini R
    Clin Hemorheol Microcirc; 2000; 23(2-4):225-32. PubMed ID: 11321444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anticardiolipin antibodies in patients with Buerger's disease].
    Cnotliwy M; Gutowski P; Szumiłowicz H; Kucharska E; Jastrzebska M; Ostanek L
    Wiad Lek; 1999; 52(7-8):332-6. PubMed ID: 10540577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Histologic characteristics of the pathologic processes in thromboangiitis obliterans (Buerger's disease)].
    Fujimoto T; Usui N; Kakinoki E; Uemichi A; Kinoshita H
    Nihon Geka Gakkai Zasshi; 1990 Oct; 91(10):1628-35. PubMed ID: 2263246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One of the most frequent vascular diseases in northeastern of Turkey: Thromboangiitis obliterans or Buerger's disease (experience with 344 cases).
    Ates A; Yekeler I; Ceviz M; Erkut B; Pac M; Basoglu A; Kocak H
    Int J Cardiol; 2006 Jul; 111(1):147-53. PubMed ID: 16580754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of anti-neutrophil cytoplasmic antibodies in patients with thromboangiitis obliterans (Buerger's disease).
    Halacheva KS; Manolova IM; Petkov DP; Andreev AP
    Scand J Immunol; 1998 Nov; 48(5):544-50. PubMed ID: 9822265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA antigens in Burger's disease.
    Zervas J; Vayopoulos G; Konstantopoulos K; Zervas C; Liapis C; Kaklamanis P; Sechas M
    Clin Rheumatol; 1991 Dec; 10(4):434-6. PubMed ID: 1802501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Etiological mechanism of the aortitis syndrome].
    Ueda H
    Nihon Rinsho; 1968 Nov; 26(11):3300-7. PubMed ID: 5752325
    [No Abstract]   [Full Text] [Related]  

  • 20. Are anticardiolipin antibodies really important in thromboangiitis obliterans (Buerger's disease)?
    Olin JW
    Vasc Med; 2002; 7(4):257-8. PubMed ID: 12710839
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.